Nestle SA CEO Mark Schneider downplayed the impact of GLP-1 weight-loss drugs on the world's largest food company, emphasizing the company's focus on expanding its range of products with reduced calorie content.In a Bloomberg TV interview,...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Accept CookiesPrivacy policy
